MARLBOROUGH, Mass., March 30, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2017 on Thursday, April 27, 2017 at 8:00 a.m. EDT.  The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer.  The company will issue a news release announcing financial results for the first quarter on Thursday, April 27, 2017, prior to the conference call.

In addition, Boston Scientific will host and webcast an Investor Day business review meeting for the investment community on Tuesday, June 27, 2017. (Note that this is a revised date from the originally scheduled May 4, 2017 event.)  The webcast and formal portions of the meeting are scheduled to begin at 7:30 a.m. EDT and expected to adjourn at approximately 1:00 p.m.  Mike Mahoney will host the meeting, which will include presentations by Boston Scientific senior management as well as question-and-answer sessions.

A live webcast of each presentation and question-and-answer session will be available via the Boston Scientific website. Webcast registration will be available on the Investor Relations section of the website at www.bostonscientific.com/investors. Registration at least 15 minutes prior to the scheduled start time is encouraged to ensure a timely connection.

Replays will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the meeting.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

SOURCE Boston Scientific Corporation